Written by: Dr. Albana Greca Sejdini, MD, MMedSc
Medically reviewed by: Dr. Ruden Cakoni, MD, Endocrinologist
Last medically reviewed: July 2026
Gestational diabetes usually causes no obvious symptoms, so blood testing is an important part of prenatal care. Most people who were not already found to have diabetes are screened between 24 and 28 weeks of pregnancy. Earlier testing may be recommended when there is a previous history of gestational diabetes, obesity, polycystic ovary syndrome, a strong family history, an earlier large baby, or another reason to suspect preexisting diabetes or high-risk abnormal glucose metabolism.
For most pregnancies without previously identified diabetes, screening is performed at 24–28 weeks. Insulin resistance normally increases during the second and third trimesters because placental hormones change how the body responds to insulin. This is why a normal early result does not always replace routine testing later in pregnancy.
Testing may occur earlier when the patient:
Risk-factor lists and screening policies vary by country. Some health systems screen all pregnant patients; others use risk-based early testing followed by routine testing at 24–28 weeks.
Testing early in pregnancy has two related goals:
The clinician may use fasting plasma glucose, HbA1c, random plasma glucose, or an early OGTT depending on the health system and clinical situation.
HbA1c is not the preferred stand-alone test for diagnosing gestational diabetes at 24–28 weeks. Pregnancy changes red-blood-cell turnover, and HbA1c does not show the same information as a glucose challenge or OGTT.
A normal early test may still need to be repeated at 24–28 weeks because pregnancy-related insulin resistance increases later.
This approach is commonly used in the United States.
The glucose challenge test is a screening test, not the final diagnostic test.
Clinics use different positive-screen thresholds, commonly 130, 135, or 140 mg/dL at one hour. A lower cutoff detects more possible cases but also sends more people for the diagnostic test.
A result above the clinic’s threshold means that a diagnostic OGTT is usually needed. It does not automatically mean that you have gestational diabetes.
After an overnight fast, blood is drawn before the drink and at one, two, and three hours after consuming 100 grams of glucose.
The commonly used Carpenter-Coustan thresholds are:
| 100-g OGTT time | Abnormal at or above | mmol/L equivalent |
|---|---|---|
| Fasting | 95 mg/dL | 5.3 mmol/L |
| 1 hour | 180 mg/dL | 10.0 mmol/L |
| 2 hours | 155 mg/dL | 8.6 mmol/L |
| 3 hours | 140 mg/dL | 7.8 mmol/L |
Under the traditional two-step method, gestational diabetes is generally diagnosed when two or more values meet or exceed the thresholds. One abnormal result may still be associated with increased pregnancy risk and may lead to nutrition counseling, repeat testing, home monitoring, or closer follow-up depending on the clinician.
The one-step strategy skips the separate 50-g screening test. After an overnight fast:
The commonly used IADPSG/ADA/WHO thresholds are:
| 75-g OGTT time | Gestational diabetes at or above | mmol/L equivalent |
|---|---|---|
| Fasting | 92 mg/dL | 5.1 mmol/L |
| 1 hour | 180 mg/dL | 10.0 mmol/L |
| 2 hours | 153 mg/dL | 8.5 mmol/L |
With this approach, one or more values meeting or exceeding the threshold establishes the diagnosis.
There is no single worldwide testing strategy. Different professional organizations and health systems may use:
The United Kingdom, for example, commonly uses a 75-g OGTT with different diagnostic criteria from the IADPSG/ADA one-step table.
The general adult “normal range” of 65–105 mg/dL should not be used to interpret all pregnancy test results. Each test has a specific glucose load, timing, and threshold.
They may identify concerning hyperglycemia, but they are not interchangeable with a standardized gestational diabetes protocol.
A fasting value may help identify preexisting diabetes or abnormal early-pregnancy glucose. It may also be one component of a 75-g or 100-g OGTT. A single fasting value does not replace the complete diagnostic test when the maternity protocol requires an OGTT.
A random test may be useful when symptoms or severe hyperglycemia are present. “Random” means the sample is taken without regard to the last meal; it does not mean blood is routinely drawn three times before, during, and after meals.
A glucose level two hours after an ordinary meal is useful for monitoring after diagnosis, but the meal does not contain a standardized amount of carbohydrate. It is not the same as an OGTT and should not be called the “second best” diagnostic test.
Glucose in urine is not accurate enough to diagnose or rule out gestational diabetes. Pregnancy changes the kidney threshold for glucose, so glycosuria can occur without gestational diabetes and gestational diabetes can occur without glycosuria.
Fasting is usually not required, but follow your clinic’s written instructions. Some clinics advise avoiding a very sugary meal immediately before testing.
The old instruction to consume at least 150 grams of carbohydrate for three days reflects older OGTT-preparation protocols. Some laboratories still provide carbohydrate guidance, while others advise the patient simply to maintain a normal unrestricted diet. Follow your laboratory’s protocol rather than a universal online rule.
Plan to remain at the laboratory for the entire testing period.
Tell the staff immediately if you vomit, feel faint, develop severe nausea, or cannot finish the drink. Vomiting may invalidate the test, but do not decide this yourself or leave without speaking to the staff.
Bring reading material, wear clothing that allows easy blood draws, and consider having someone accompany you if you have a history of fainting or severe nausea.
Temporary symptoms may include:
Most symptoms resolve after the test and a permitted meal. Ask the clinic when you may eat, drink, drive, and take morning medicines.
A standard glucose drink does not cause gestational diabetes. It temporarily challenges the body with a measured glucose amount so the response can be assessed.
After gastric bypass or another procedure associated with dumping syndrome, a standard glucose drink may cause severe symptoms and unreliable results. Some patients also cannot complete an OGTT because of recurrent vomiting or another medical condition.
There is no single universal substitute. The obstetric and diabetes teams may consider structured fasting and post-meal home glucose monitoring, continuous glucose monitoring, or another locally approved strategy. Do not substitute home readings without a documented clinical plan.
An abnormal diagnostic result means that pregnancy-related insulin resistance has exceeded the pancreas’s ability to maintain glucose below the selected thresholds.
It does not mean that:
It does mean that treatment and monitoring should begin promptly because managing glucose reduces pregnancy risks.
Possible risks of untreated or insufficiently controlled gestational diabetes include:
Most people with gestational diabetes can have a healthy pregnancy and baby with appropriate care.
These are treatment targets, not OGTT diagnostic thresholds.
| Home monitoring time | Common ADA target | mmol/L |
|---|---|---|
| Fasting | Below 95 mg/dL | Below 5.3 mmol/L |
| 1 hour after beginning a meal | Below 140 mg/dL | Below 7.8 mmol/L |
| 2 hours after beginning a meal | Below 120 mg/dL | Below 6.7 mmol/L |
Your maternity team may use different goals based on the pregnancy, glucose method, medication, fetal growth, and hypoglycemia risk.
A reading of 140 mg/dL has a different meaning when it is:
Always record the timing.
Care commonly includes:
Insulin is the preferred medicine in many guidelines when lifestyle measures are insufficient because it does not cross the placenta. Metformin is used in some health systems after individualized discussion, but it crosses the placenta and is not appropriate for every patient.
Do not start supplements, herbs, a ketogenic diet, prolonged fasting, or severe carbohydrate restriction to lower pregnancy glucose.
Read Gestational Diabetes Diet and Treatment Strategies and Tips for Controlling Gestational Diabetes.
Yes. Glucose often improves after delivery when placental hormones fall, but this should be confirmed.
ADA 2026 recommends:
The postpartum OGTT is preferred over HbA1c alone during the early postpartum period because blood loss, pregnancy-related changes in red-cell turnover, and iron status can affect HbA1c.
A history of gestational diabetes also increases the chance of recurrence in a later pregnancy. Tell future maternity teams early, even when postpartum glucose was normal.
Contact the maternity or diabetes team promptly for:
The 50-g screening test is usually nonfasting. Follow your clinic’s instructions because local protocols differ.
The clinic may use a cutoff of 130, 135, or 140 mg/dL. A value below its selected threshold usually means no diagnostic OGTT is needed unless there is another clinical concern.
No. It usually means the diagnostic 100-g OGTT is needed. Some clinics use a one-step 75-g strategy instead.
Water is commonly permitted, but confirm with the laboratory. Do not drink flavored, sweetened, or caloric beverages.
Usually no. Physical activity can change glucose handling. Remain seated or resting unless staff instructs otherwise.
Tell the staff immediately. The test may need to be stopped and repeated or replaced with another clinically approved strategy.
Not routinely at 24–28 weeks. HbA1c does not provide the same diagnostic information as a pregnancy OGTT.
Yes, although it is less common. Contact the maternity team if later fetal growth, symptoms, glucose readings, medicines, or another clinical finding raises concern.
Glucose often returns to normal, but not always. A postpartum 75-g OGTT is required to check for persistent diabetes or prediabetes.
Medical disclaimer: This page provides general education and cannot select your pregnancy screening method, diagnose gestational diabetes, or replace your obstetric or diabetes team. Follow the exact preparation instructions and diagnostic thresholds supplied by your maternity clinic and laboratory.